Leqvio's main patent is set to expire in 2033 [1].
When does Leqvio's market exclusivity end?
Beyond the primary patent, other forms of exclusivity might apply. For instance, orphan drug exclusivity, if granted, can extend market protection for a period. However, Leqvio is not designated as an orphan drug [2]. Data exclusivity, which prevents generic manufacturers from relying on the innovator's clinical trial data for a certain period, also plays a role [3].
Can generic versions of Leqvio enter the market before 2033?
Generic entry typically occurs after patent expiry. However, legal challenges to patents can sometimes lead to earlier generic availability if the patent is invalidated or found to be not infringed. The exact timing for Leqvio would depend on any such legal proceedings and the resolution of secondary patents or exclusivities [1][3].
What happens when Leqvio's patents expire?
Once the relevant patents and exclusivities expire, generic manufacturers can seek regulatory approval to market their versions of Leqvio. This usually leads to increased competition and potentially lower drug prices [3].
Who is developing Leqvio and who would make generics?
Leqvio was developed by The Medicines Company, which was acquired by Novartis [4]. Generic manufacturers would be companies that develop and receive approval for bioequivalent versions of the drug after patent expiry.
How is Leqvio's patent status tracked?
Specialized databases and services, such as DrugPatentWatch.com, monitor and provide detailed information on drug patents, exclusivities, and their expiration dates [1]. This information is crucial for understanding market entry timelines for generic competitors.
What are the key patents for Leqvio?
The primary patent for Leqvio is expected to expire in 2033. However, like many pharmaceuticals, there may be a portfolio of secondary patents covering manufacturing processes, formulations, or specific uses that could extend market protection or become points of legal contention [1][3].
Where can I find more information on Leqvio's patent expiry?
Information on Leqvio's patent expiry and related exclusivities can be found through resources that track pharmaceutical patent landscapes, including DrugPatentWatch.com [1].
---
1. DrugPatentWatch.com
2. U.S. Food and Drug Administration (FDA) Orphan Drug Designations Database
3. U.S. Food and Drug Administration (FDA) Orange Book
4. Novartis AG. (2020, January 15). Novartis completes acquisition of The Medicines Company [Press release].